» Articles » PMID: 35690780

Associations of C-reactive Protein Isoforms with Systemic Lupus Erythematosus Phenotypes and Disease Activity

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2022 Jun 11
PMID 35690780
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by a large production of autoantibodies and deficient clearance of cellular waste. The disease typically oscillates between episodes of elevated disease activity and quiescent disease. C-reactive protein (CRP) is a pentameric acute-phase protein usually reflecting inflammation and tissue damage. However, despite increased inflammation and elevated interleukin-6, the levels of CRP typically remain low or only slightly raised in SLE. Under certain conditions, pentameric CRP (pCRP) can dissociate into its monomeric isoform (mCRP), which mainly has been ascribed pro-inflammatory properties. The present study aims to investigate the potential relationship between pCRP and mCRP, respectively, with disease activity and clinical features of SLE.

Methods: The levels of pCRP and mCRP were measured, by turbidimetry (high-sensitive) and sandwich enzyme-linked immunosorbent assay (ELISA) respectively, in serum samples from 160 patients with SLE and 30 patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Twenty-two of the SLE cases were selected for analysis at two time-points; quiescent disease and active disease. The two CRP isoforms were evaluated in relation to disease activity and clinical features in the two diseases.

Results: Levels of pCRP and mCRP were significantly lower in SLE than AAV (p < 0.001) and the ratio of mCRP/pCRP was higher in SLE compared to AAV. The mCRP/pCRP ratio was higher for patients in remission and able to significantly separate between active/quiescent disease in paired, but not in non-paired, samples from patients with SLE. Significant correlations were observed with SLICC/ACR damage index for pCRP levels as well as inversely with the mCRP/pCRP ratio. Lower mCRP levels associated with malar rash.

Conclusion: As the interrelationship between the two isoforms appear to (a) discriminate between quiescent and active SLE and (b) differ between SLE and AAV, our data indicates that the two CRP isoforms could exert contrasting immunological effects and/or reflect different milieus. Given the biological effects of mCRP, it is possible that altered levels may indicate increased opsonization of immune complexes and apoptotic debris, and thereby prevent their deposition outside the reticuloendothelial system and manifestations such as lupus nephritis and lupus-related skin disease.

Citing Articles

Higher monomeric C-reactive protein levels are associated with premature coronary artery disease.

Melnikov I, Kozlov S, Okhota S, Saburova O, Avtaeva Y, Kuznetsova T Front Immunol. 2025; 15:1501125.

PMID: 39867895 PMC: 11757105. DOI: 10.3389/fimmu.2024.1501125.


Profiles of systemic lupus erythematosus patients with co-existing sickle cell disease: a coincidence or true association?.

Olaosebikan H, Igebu E, Orolu A, Odunlami G, Bamisebi I, Dada A Reumatologia. 2025; 62(6):430-438.

PMID: 39866301 PMC: 11758103. DOI: 10.5114/reum/195432.


Serum p-Glycoprotein and Monomeric C-Reactive Protein are Elevated in Takayasu Arteritis.

Thakare D, Singh K, Qamar T, Singh D, Balakrishnan S, Rathore U J Inflamm Res. 2024; 17:8695-8712.

PMID: 39553310 PMC: 11566576. DOI: 10.2147/JIR.S490958.


C-reactive Protein: An Inflammatory Biomarker and a Predictor of Neurodegenerative Disease in Patients With Inflammatory Bowel Disease?.

Muresan S, Slevin M Cureus. 2024; 16(4):e59009.

PMID: 38665135 PMC: 11045161. DOI: 10.7759/cureus.59009.


The Role of Anti-mCRP Autoantibodies in Lupus Nephritis.

Yuan M, Tan Y, Zhao M Kidney Dis (Basel). 2023; 9(5):317-325.

PMID: 37901707 PMC: 10601961. DOI: 10.1159/000530928.


References
1.
Sjowall C, Zickert A, Skogh T, Wettero J, Gunnarsson I . Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis. Arthritis Res Ther. 2009; 11(6):R188. PMC: 3003497. DOI: 10.1186/ar2880. View

2.
Frodlund M, Dahlstrom O, Kastbom A, Skogh T, Sjowall C . Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register. BMJ Open. 2013; 3(10):e003608. PMC: 3808756. DOI: 10.1136/bmjopen-2013-003608. View

3.
Fernandez-Botran R, Plankey M, Ware D, Bordon J . Changes in liver steatosis in HIV-positive women are associated with the BMI, but not with biomarkers. Cytokine. 2021; 144:155573. PMC: 8607847. DOI: 10.1016/j.cyto.2021.155573. View

4.
Skogh T, Stendahl O . Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system. Immunology. 1983; 49(1):53-9. PMC: 1454113. View

5.
Sjowall C, Eriksson P, Almer S, Skogh T . Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjögren's syndrome, rheumatoid arthritis or inflammatory bowel disease. J Autoimmun. 2002; 19(3):155-60. DOI: 10.1006/jaut.2002.0608. View